Mahamaya Lifesciences Limited · BSE:MAHALIFE

Mahamaya Lifesciences — H1 FY27 Earnings Presentation

32 slides from Mahamaya Lifesciences's earnings presentation, Nov 19, 2026

  1. Slide 1: BSE filing cover letter for investor presentation

    Date: November 19, 2026 To, The Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 544611 Subject: Investor Presentation on Unaudited Financial Result (standalone and consolidated) for the half year ended September 30, 2026 Dear Sir / Mada

  2. Slide 2: Investor Presentation H1 FY27

    INVESTOR PRESENTATION H1 FY27

  3. Slide 3: Safe Harbour

    SAFE HARBOUR This document has been prepared for information purposes only and is not an offer or invitation or recommendation to buy or sell any securities of Mahamaya Life Sciences Limited(Company) nor shall part, or all, of this document form the basis of, or be relied on in connection with, any

  4. Slide 4: Index

    INDEX H1FY27 Highlights Company Overview Manufacturing Capabilities Awards & Exhibitions Industry Overview Historical Financial Highlights 3

  5. Slide 5: Mahamaya at a Glance

    MAHAMAYA AT A GLANCE Mahamaya Lifesciences Limited is engaged in the import, manufacturing, export and distribution of agrochemical and plant nutrition products, catering to institutional customers and retail farming communities. The Company's product portfolio comprises herbicides, insecticides, fu

  6. Slide 6: Management Commentary

    MANAGEMENT COMMENTARY We are pleased with our consolidated financial performance during H1 FY27, with Revenue from Operations growing 29.78% YoY to ₹211.63 crore. EBITDA increased 41.54% to ₹23.16 crore, with margins expanding by 93 basis points to 10.95%, while PAT grew 38% to ₹11.55 crore. We are

  7. Slide 7: H1 FY27 Key Highlights (Consolidated)

    H1 FY27 KEY HIGHLIGHTS (CONSOLIDATED) All Rs. in Lakhs except % Revenue From Operations (Incl. Other Operating Income) EBITDA Profit After Tax (PAT) HoH: +27.57% YoY: +29.52% HoH: +29.41% YoY: +41.54% HoH: +41.62% YoY: +38.00% 2,316.33 1,154.87 21,162.92 1,789.85 836.88 16,338.89 16,589.74 1,636.47

  8. Slide 8: Consolidated Profit & Loss Statement

    CONSOLIDATED PROFIT & LOSS STATEMENT (Rs. in lakhs) PARTICULARS H1 FY 27 H2 FY26 HOH% H1 FY26 YOY% FY 26 Revenue From Operations (Incl. Other 21,162.92 16,589.74 27.57% 16,338.89 29.52% 32,928.63 Operating Income) Other Income 79.78 43.77 82.27% 30.83 158.77% 74.6 Total Income 21,242.70 16,633.51 27

  9. Slide 9: Consolidated Balance Sheet

    CONSOLIDATED BALANCE SHEET (Rs. in lakhs) Particulars Sep 2026 Mar 2026 Assets Sep 2026 Mar 2026 Equity and Liabilities Non Current Assets Shareholder's Fund Property, Plant and Equipment 2,999.22 2,308.32 Share Capital 2,340.50 2,340.50 Capital Work in Progress 331.13 574.35 Reserves and Surplus 11

  10. Slide 10: Our Journey

    OUR JOURNEY Industry Recognition- One of the top 10 Pesticides and Insecticides Manufacturers. Certified by Industry Outlook Established by Mr. Krishnamurthy Ganesan and Mrs. Lalitha Established dedicated Emamectin Benzoate 5% SG 300 crore+ Turnover Krishnamurthy, initially focusing on Registrations

  11. Slide 11: Our Business Model

    OUR BUSINESS MODEL Bulk Formulation Domestic Branded Technical Sales Export Sales Supply Sales(B2C) Manufacturing and Selling concentrated Crop-protection Supplying formulated supplying formulations in pesticide active ingredients solutions under own agrochemical products to bulk to domestic and (te

  12. Slide 12: Product Portfolio

    PRODUCT PORTFOLIO A Diversified Portfolio Across Chemical & Biological Crop-Care Solutions Conventional Agrochemicals Biological & Specialty Products Insecticides Biostimulants & PGRs Solutions supporting plant growth and physiological Solutions for managing insect and pest infestations. processes.

  13. Slide 13: Product Offerings

    PRODUCT OFFERINGS Varied portfolio comprising insecticides, fungicides, herbicides, bio- stimulants/PGRs, biopesticides & biofertilizer. Export Sales Active Ingredient Formulation Type Bio Stimulants Bio Fertilizer Herbicides Insecticides Fugicides Wiper Sulphur 80% WDG Lancha Pendimethalin 50% EC T

  14. Slide 14: Product Registration & Brand Launches

    PRODUCT REGISTRATION & BRAND LAUNCHES Continuous Product Additions Through Regulatory & R&D Capabilities Other Categories Registration Approved Registration Pipeline PGR 3% 1.7% 2 15 Herbicides 19.1% 19 19 Formulation Formulation Technical Technical exclusively for Import Formulation Insecticides Im

  15. Slide 15: State of the Art Manufacturing Facility

    STATE OF THE ART MANUFACTURING FACILITY Dahej, Gujarat Commissioned: 2021 Formulation manufacturing facility at Dahej for producing agrochemical formulations. The facility supports the company's bulk formulation sales, branded products and exports to meet the demand. Manufacturing Capacity Manufactu

  16. Slide 16: R&D & Product Development Capabilities

    R&D & PRODUCT DEVELOPMENT CAPABILITIES IN-HOUSE RESEARCH, FORMULATION DEVELOPMENT & PROCESS INNOVATION CORE R&D CAPABILITIES New Formulations Product Optimisation Development of new crop-care formulations. Improving formulation performance and cost efficiency. Process Development Innovation Developi

  17. Slide 17: Expanding Manufacturing Capabilities & Strengthening Integration

    EXPANDING MANUFACTURING CAPABILITIES & STRENGTHENING INTEGRATION 1.Backward Integration – Technical Manufacturing Planned project Establishing an in-house technical manufacturing at existing facility at Dahej Planned capacity Project investment 250 MTPA ~₹30 Cr Technical manufacturing Through IPO pr

  18. Slide 18: Geographical Presence

    GEOGRAPHICAL PRESENCE Domestic Presence International Presence Expanding Global footprint in Crop Production United Arab Emirates. Mahamaya Lifesciences FZE (Wholly owned subsidiary) 17 17

  19. Slide 19: Marquee Clientele

    MahaMaya. -MAHAMAYA LIFESCIENCES | MARQUEE CLIENTELE ® ‘YS >) ze ~ >) anVvuU yy a RALLIS INDIA LIMITED | | Bharat RASAYAN LIMITED anu D. A TATA Enterprise "a C * i B 2 u|{ A) Atul DCM SHRIRAM Payer Coromandel = Growing with trust R FUTURE POSITIVE a >) a a (— © | IFFco-Mc) > |. g SUMITOMO CHEMICAL I

  20. Slide 20: Participation in Industry Leading Exhibitions

    PARTICIPATION IN INDUSTRY LEADING EXHIBITIONS 19

  21. Slide 21: Awards & Recognition

    | AWARDS & RECOGNITION Mahaffiage” MAHAMAYALFESCIENCES. D Globalist cum rac nasa - © ADHERENCE TO GLOBAL LX cunury sravoneos cow) Mahamaya Lifesciences limited got BE Business Connect ADE 0 aL CERTIFICATE OF APPRECIATION ‘THIS CERTIFICATE Is PROUDLY PRESENTED TO Mahamaya Lifesciences limited

  22. Slide 22: Key Managerial Personnel

    KEY MANAGERIAL PERSONNEL PRASHANT KRISHNAMURTHY KRISHNAMURTHY GANESAN Managing Director Chairman M.S., University of 15+ Years Post 45 Years Warwick, UK Graduation(Chemicals), Madras University Oversees the Company’s international business Prior experience in Coromandel Indag & Montari operations an

  23. Slide 23: Board of Directors

    BOARD OF DIRECTORS Dr. Charudatta Digambar Mayee Mr. Sekhar Kavasseri Rajagopalan Dr. Gopal Krishna Raju Dr. Bhagirath Choudhary Independent Director Independent Director Independent Director Independent Director An accomplished agricultural scientist with expertise in plant A certified ESG speciali

  24. Slide 24: Why Mahamaya?

    WHY MAHAMAYA? Strengths that support our journey from product development to global markets 01 | Diversified Product Portfolio Comprehensive product portfolio spanning insecticides, fungicides, herbicides, biostimulants, plant growth regulators (PGRs), biopesticides and biofertilizers, catering to d

  25. Slide 25: Understanding the Agrochemical Industry

    UNDERSTANDING THE AGROCHEMICAL INDUSTRY 01 | AGROCHEMICAL INDUSTRY VALUE CHAIN 02 | KEY BARRIERS TO ENTRY Technical Grade Manufacturing Regulatory & Product Registration Production of active ingredients (technical-grade molecules) Product-specific registrations, regulatory documentation and that pro

  26. Slide 26: Indian Agrochemical Market

    INDIAN AGROCHEMICAL MARKET AGROCHEMICAL INDUSTRY IN INDIA: MARKET OVERVIEW MARKET SHARE BY PRODUCT TYPE, 2024 India Agrochemicals Industry – Market Size (USD Billion) Fertilizers – 53.46% 46.54% 53.46% Combined Share of Pesticides, Adjuvants USD 13.81 B & More – 46.54% % GR 6.18 CA USD 10.23 B KEY G

  27. Slide 27: Global Agrochemical Market

    GLOBAL AGROCHEMICAL MARKET Agrochemicals Market - Market Size in USD Billion ASIA-PACIFIC | THE LARGEST AND FASTEST-GROWING AGROCHEMICAL MARKET USD 412.40 B 5.40% CAGR USD 317 B USD 300.80 B 53% 6.66% Asia-Pacific market Projected CAGR share 2025 2025–2031 2025 2026 2031 PRODUCT CATEGORY KEY DATA KE

  28. Slide 28: Agrochemical Industry - Asia Pacific & World

    AGROCHEMICAL INDUSTRY - ASIA PACIFIC & WORLD India Agrochemical Market Market Share- by Product Type India is a major agrochemical manufacturing and Asia Pacific World export hub. Multi-source generics account for around 85% of the 6.6% 9.5% 8.1% market, creating opportunities as global molecules lo

  29. Slide 29: Growth Outlook & Strategic Priorities

    GROWTH OUTLOOK & STRATEGIC PRIORITIES FY27 OUTLOOK MARGIN IMPROVEMENT ~30-35% PROFITABILITY FOCUS DRIVEN BY OPERATING EFFICIENCIES, BACKWARD INTEGRATION AND PRODUCT MIX IMPROVEMENT. TARGETED REVENUE GROWTH SUSTAINED GROWTH ACROSS TECHNICAL, FORMULATION AND BRANDED PRODUCTS. KEY GROWTH DRIVERS LONG-T

  30. Slide 30: Key Historical Performance (Consolidated)

    KEY HISTORICAL PERFORMANCE (CONSOLIDATED) All Rs. in Lakhs except % Revenue From Operations EBITDA Profit After Tax (PAT) (Incl. Other Operating Income) 3% 3,426.32 33.9 32,928.63 9% 93% 1,652.33 CAG R R 54.8 63. CAG GR CA 26,575.02 2,594.42 1,281.16 16,157.08 13,707.58 1,450.23 922.06 521.86 375.06

  31. Slide 31: Key Ratios (Consolidated)

    KEY RATIOS (CONSOLIDATED) ROE In % ROCE In % In ₹ Historical EPS (Diluted) 34.94% 25.18% 8.33 23.15% 7.5 23.67% 19.29% 16.16% 3.26 FY24 FY25 FY26 FY24 FY25 FY26 FY24 FY25 FY26 Debt – Equity Ratio In Times PAT Margin In % Current Ratio In Times 2.22 4.82% 5.02% 1.45 1.12 1.19 3.23% 1.18 0.74 FY24 FY2

  32. Slide 32: Thank You

    THANK YOU Kush Mishra Abhishek Bhutra | Himanshu Jain (Company Secretary) https://www.mahamayalifesciences.com/ +91 80006 85556 | 91 99987 81853 cs@mahamayalifesciences.com invrel@finportalin.com Request Meeting & Investor kit

Mahamaya Lifesciences — H1 FY27 Earnings Presentation on 6ix